Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y686-p , Y934-p , Y970-p
Arg Y686-p
GRK2 S1104-p
PDGFRB Y751-p , Y763-p , Y771-p , Y775-p , Y778-p , Y857-p , Y1009-p , Y1021-p
PKG2 S712-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

PDGFRB Y562-p , Y579-p , Y581-p , Y740-p , Y751-p , Y771-p , Y857-p , Y1009-p , Y1021-p
Phosphatases, in vitro:
ACP1 Y751-p , Y857-p , Y1021-p
PTPRJ Y751-p , Y763-p , Y771-p , Y775-p , Y778-p , Y1009-p , Y1021-p
SHP-2 Y771-p
Putative upstream phosphatases:
PTP1B Y740-p , Y751-p , Y771-p , Y1009-p , Y1021-p
PTPRJ Y562-p , Y751-p , Y857-p , Y1009-p , Y1021-p
SHP-2 Y740-p , Y751-p , Y771-p
Regulatory protein:
PDGFRB Y751-p , Y857-p
PIK3C2A Y740-p , Y751-p , Y771-p , Y1009-p , Y1021-p
RAC1 Y740-p , Y751-p , Y771-p , Y1009-p , Y1021-p
Treatment:
4-HT Y751-p
8pCPT-cGMP S712-p
9cRA Y751-p
AG1296 Y1021-p
AG17 Y1021-p
angiotensin Y751-p , Y1021-p
candesartan Y1021-p
dexamethasone Y751-p
LY294002 Y740-p , Y751-p , Y771-p , Y1009-p , Y1021-p
PD168077 Y1021-p
PDGF Y579-p , Y581-p , Y716-p , Y740-p , Y751-p , Y763-p , Y771-p , Y775-p , Y778-p , Y857-p , Y1009-p , Y1021-p
PP2 Y1021-p
quinpirole Y1021-p
raclopride Y1021-p
retinoic_acid Y751-p
tamoxifen Y751-p
vanadate Y579-p , Y581-p , Y771-p , Y857-p
wortmannin Y740-p , Y751-p , Y771-p , Y1009-p , Y1021-p